PDE2A Antikörper
-
- Target Alle PDE2A Antikörper anzeigen
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PDE2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC)
- Produktmerkmale
- Homo sapiens phosphodiesterase 2A, cGMP-stimulated (PDE2A), transcript variant 1
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human PDE2A (NP_002590) produced in HEK293T cell.
- Klon
- 1G9
- Isotyp
- IgG1
- Top Product
- Discover our top product PDE2A Primärantikörper
-
-
- Applikationshinweise
- WB 1:2000, IHC 1:150, FLOW 1:100
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
-
A PKG inhibitor increases Ca(2+)-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition." in: American journal of physiology. Gastrointestinal and liver physiology, Vol. 304, Issue 9, pp. G773-80, (2013) (PubMed).
: "
-
A PKG inhibitor increases Ca(2+)-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition." in: American journal of physiology. Gastrointestinal and liver physiology, Vol. 304, Issue 9, pp. G773-80, (2013) (PubMed).
-
- Target
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
- Andere Bezeichnung
- PDE2A (PDE2A Produkte)
- Molekulargewicht
- 105.5 kDa
- Gen-ID
- 5138
- NCBI Accession
- NM_002599
- HGNC
- 5138
- Pathways
- cAMP Metabolic Process, Synaptic Membrane
-